← Back to companies
Amber Bio
0 open3 filled
San Francisco, California, United StatesFounded 202221+ employeesSeed raisedSeedPrivate
Last round: seed · $26M · Aug 2023(1 rounds total)
Founded by Basem Al-Shayeb, Jacob Borrajo
Backed by(7 investors)
Playground GlobalAndreessen HorowitzSV AngelHummingbird VenturesPillar VCRetinal Degeneration FundEli Lilly
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations. The current paradigm in genetic medicine relies on developing independent therapies for each separate mutation in the patient population. Founded by pioneers in the CRISPR field from leading institutions for gene editing research, the company is developing a first-of-its-kind RNA writing platform capable of editing thousands of diverse mutations across patients with a single product.
Open Positions at Amber Bio (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Amber Bio?
